observational
    2002

    Methylsulfonylmethane for seasonal allergic rhinitis: a pilot multicenter open-label study

    Barrager E, Veltmann JR, Schauss AG, Schiller RN

    Published in Journal of Alternative and Complementary Medicine

    Key Findings

    Respiratory and total symptom scores fell over 30 days of MSM 2600 mg/day, with no change in inflammatory biomarkers.

    Conclusions

    Uncontrolled, no biomarker corroboration.

    Limitations

    Open label, no placebo.

    Supplements Studied

    MSM
    Compound

    Allergic rhinitis symptom scores fell during open-label MSM use, with no change in inflammatory biomarkers.

    Sulfur
    Mineral

    Respiratory and total symptom scores fell over 30 days of MSM 2600 mg/day, with no change in inflammatory biomarkers.

    Related Health Concerns

    Allergic Rhinitis

    Study Details

    Year:2002
    Sample Size:50
    Duration:4 weeks
    Quality Score:2/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.